cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.48370/ofd/xbwtbp/chkutm
title: HMW_Vicia_grandiflora_Scop._H_4802.jpg

description: :unav
DOI: 10.48370/ofd/xbwtbp
title: Wyka brudnożółta (Vicia grandiflora Scop.), 4802

description: Herbarium
DOI: 10.48370/ofd/2azhek/xvgx0q
title: HMW_Vicia_grandiflora_Scop._H_5181.jpg

description: :unav
DOI: 10.48370/ofd/2azhek
title: Wyka brudnożółta (Vicia grandiflora Scop.), 5181

description: Herbarium
DOI: 10.48370/ofd/ybpjua/zupjzc
title: HMW_Vicia_grandiflora_Scop._H_6405.jpg

description: :unav
DOI: 10.48370/ofd/ybpjua
title: Wyka brudnożółta (Vicia grandiflora Scop.), 6405

description: Herbarium
DOI: 10.48370/ofd/haruog/k2scha
title: HMW_Vicia_grandiflora_Scop._H_6854.jpg

description: :unav
DOI: 10.48370/ofd/haruog
title: Wyka brudnożółta (Vicia grandiflora Scop.), 6854

description: Herbarium
DOI: 10.48370/ofd/abvsb8/87ifna
title: HMW_Veronica_spicata_L._H_3244.jpg

description: :unav
DOI: 10.48370/ofd/abvsb8
title: Przetacznik kłosowy (Veronica spicata L.), 3244

description: Herbarium
DOI: 10.48370/ofd/euvgf7/mmak7s
title: HMW_Veronica_spicata_L._H_3612.jpg

description: :unav
DOI: 10.48370/ofd/euvgf7
title: Przetacznik kłosowy (Veronica spicata L.), 3612

description: Herbarium
DOI: 10.48370/ofd/dmbjbs/dkseu4
title: HMW_Veronica_spicata_L._H_4088.jpg

description: :unav
DOI: 10.48370/ofd/dmbjbs
title: Przetacznik kłosowy (Veronica spicata L.), 4088

description: Herbarium
DOI: 10.48370/ofd/fogfe4/40hvkx
title: HMW_Veronica_spicata_L._H_6148.jpg

description: :unav
DOI: 10.48370/ofd/fogfe4
title: Przetacznik kłosowy (Veronica spicata L.), 6148

description: Herbarium
DOI: 10.48370/ofd/bpiuyd/gbde0j
title: HMW_Veronica_spicata_L._H_6194.jpg

description: :unav
DOI: 10.48370/ofd/bpiuyd
title: Przetacznik kłosowy (Veronica spicata L.), 6194

description: Herbarium
DOI: 10.48370/ofd/3iedrs/lphtd2
title: HMW_Veronica_spicata_L._H_6576.jpg

description: :unav
DOI: 10.48370/ofd/3iedrs
title: Przetacznik kłosowy (Veronica spicata L.), 6576

description: Herbarium
DOI: 10.48370/ofd/dsn2s6/rdick0
title: HMW_Veronica_spicata_L._H_6751.jpg

description: :unav
DOI: 10.48370/ofd/dsn2s6
title: Przetacznik kłosowy (Veronica spicata L.), 6751

description: Herbarium
DOI: 10.48370/ofd/71gddo/dnrcns
title: HMW_Veronica_spicata_L._H_6752.jpg

description: :unav
DOI: 10.48370/ofd/71gddo
title: Przetacznik kłosowy (Veronica spicata L.), 6752

description: Herbarium
DOI: 10.48370/ofd/edxpjp/wowlr1
title: HMW_Veronica_spicata_L._H_8323.jpg

description: :unav
DOI: 10.48370/ofd/edxpjp
title: Przetacznik kłosowy (Veronica spicata L.), 8323

description: Herbarium
DOI: 10.48370/ofd/suafyj/sqs866
title: HMW_Veronica_spicata_L._subsp._incana_(L.)_Walters_H_05482.jpg

description: :unav
DOI: 10.48370/ofd/suafyj
title: Przetacznik kłosowy siwy (Veronica spicata L. subsp. incana (L.) Walters), 5482

description: Herbarium
DOI: 10.6084/m9.figshare.16601186
title: supplementary materials for Li_et. al endometriosis manuscript

description: <b>supplementary figure 1, supplementary methods and materials, supplementary table 1 for </b>Li_et. al manuscript "<b>Higher follicular fluid progesterone down-regulated HPGD and COX2 in granulosa cells via suppressing NF-кB signaling in endometriosis</b>"
DOI: 10.6084/m9.figshare.16601186.v1
title: supplementary materials for Li_et. al endometriosis manuscript

description: <b>supplementary figure 1, supplementary methods and materials, supplementary table 1 for </b>Li_et. al manuscript "<b>Higher follicular fluid progesterone down-regulated HPGD and COX2 in granulosa cells via suppressing NF-кB signaling in endometriosis</b>"
DOI: 10.5281/zenodo.4771279
title: Stabilization of b-Glucuronidase by Immobilization in Magnetic-Silica Hybrid Supports

description: b-Glucuronidases are a class of enzymes that catalyze the breakdown of complex carbohydrates.<br> They have well documented biocatalytic applications in synthesis, therapeutics, and analytics that could<br> benefit from enzyme immobilization and stabilization. In this work, we have explored a number of<br> immobilization strategies for Patella vulgata -Glucuronidase that comprised a tailored combination of<br> biomimetic silica (Si) and magnetic nanoparticles (MNPs). The individual eect of each material on the<br> enzyme upon immobilization was first tested. Three dierent immobilization strategies for covalent<br> attachment on MNPs and dierent three catalysts for the deposition of Si particles were tested.<br> We produced nine dierent immobilized preparations and only two of them presented negligible<br> activity. All the preparations were in the micro-sized range (from 1299 52 nm to 2101 67 nm<br> of hydrodynamic diameter). Their values for polydispersity index varied around 0.3, indicating<br> homogeneous populations of particles with low probability of agglomeration. Storage, thermal,<br> and operational stability were superior for the enzyme immobilized in the composite material.<br> At 80 C dierent preparations with Si and MNPs retained 40% of their initial activity after 6 h of<br> incubation whereas the soluble enzyme lost 90% of its initial activity within 11 min. Integration of<br> MNPs provided the advantage of reusing the biocatalyst via magnetic separation up to six times with<br> residual activity. The hybrid material produced herein demonstrated its versatility and robustness as<br> a support for b-Glucuronidases immobilization.
DOI: 10.5281/zenodo.4771278
title: Stabilization of b-Glucuronidase by Immobilization in Magnetic-Silica Hybrid Supports

description: b-Glucuronidases are a class of enzymes that catalyze the breakdown of complex carbohydrates.<br> They have well documented biocatalytic applications in synthesis, therapeutics, and analytics that could<br> benefit from enzyme immobilization and stabilization. In this work, we have explored a number of<br> immobilization strategies for Patella vulgata -Glucuronidase that comprised a tailored combination of<br> biomimetic silica (Si) and magnetic nanoparticles (MNPs). The individual eect of each material on the<br> enzyme upon immobilization was first tested. Three dierent immobilization strategies for covalent<br> attachment on MNPs and dierent three catalysts for the deposition of Si particles were tested.<br> We produced nine dierent immobilized preparations and only two of them presented negligible<br> activity. All the preparations were in the micro-sized range (from 1299 52 nm to 2101 67 nm<br> of hydrodynamic diameter). Their values for polydispersity index varied around 0.3, indicating<br> homogeneous populations of particles with low probability of agglomeration. Storage, thermal,<br> and operational stability were superior for the enzyme immobilized in the composite material.<br> At 80 C dierent preparations with Si and MNPs retained 40% of their initial activity after 6 h of<br> incubation whereas the soluble enzyme lost 90% of its initial activity within 11 min. Integration of<br> MNPs provided the advantage of reusing the biocatalyst via magnetic separation up to six times with<br> residual activity. The hybrid material produced herein demonstrated its versatility and robustness as<br> a support for b-Glucuronidases immobilization.
DOI: 10.14457/cu.the.1997.394
title: Dissolution kinetics of fractionated asphaltenes
DOI: 10.14457/cu.the.1997.395
title: Activity and selectivity enhancement of HDS catalysts
DOI: 10.14457/cu.the.1997.396
title: Influence of carbon black aggregate structure on agglomerate dispersion behavior
DOI: 10.14457/cu.the.1997.397
title: Synthesis of MgAl2O4 spinel and its application as a humidity sensing element
DOI: 10.48370/ofd/cffm7s/vlk97q
title: HMW_Veronica_teucrium_L._H_1633.jpg

description: :unav
DOI: 10.14457/cu.the.1997.398
title: Amphetamine use and factors leading to amphetamine use among Assumption University students in Bangkok
DOI: 10.48370/ofd/cffm7s
title: Przetacznik pagórkowy (Veronica teucrium L.), 1633

description: Herbarium
DOI: 10.14457/cu.the.1997.399
title: Counselling services for family planning clinents : a strategy to improve contraceptive use in Nepal
DOI: 10.14457/cu.the.1997.400
title: The effect of sizing agents on the silanol condensation of silane in solution
DOI: 10.48370/ofd/ucu1m3/lj5g5t
title: HMW_Veronica_teucrium_L._H_4178.jpg

description: :unav
DOI: 10.48370/ofd/ucu1m3
title: Przetacznik pagórkowy (Veronica teucrium L.), 4178

description: Herbarium
DOI: 10.14457/cu.the.1997.401
title: Effect of surfactant carbon chain length on adsorption isotherms of molecular sieve MCM-41
DOI: 10.14457/cu.the.1997.402
title: Molecular engineering of nanocomposite polypropylene for increased resistance to slow crack growth and mechanical properties
DOI: 10.14457/cu.the.1997.403
title: The teachers child to parents approach : an intervention to improve iodised salt consumption practices for reducing iodine deficiency disorders in Nepal
DOI: 10.48370/ofd/vouori/a2jxph
title: HMW_Veronica_teucrium_L._H_5612.jpg

description: :unav
DOI: 10.14457/cu.the.1997.404
title: Yellow oil formation at acid gas removal unit in an ethylene plant
DOI: 10.48370/ofd/vouori
title: Przetacznik pagórkowy (Veronica teucrium L.), 5612

description: Herbarium
DOI: 10.14457/cu.the.1997.405
title: Interactions between the non-ionic surfactant and polyacrylamide studied by light scattering and viscometry
DOI: 10.14457/cu.the.1997.406
title: Mobilization of community health workers for early dianosis and tratment of leismaniasis in Nepal
DOI: 10.14457/cu.the.1997.407
title: Participatory action research as a tool to combat fatal delays in presenting children under five with pneumonia to a trained health worker
DOI: 10.14457/tu.the.2020.320
title: ปัจจัยที่มีผลต่อความตั้งใจรับวัคซีนโควิด 19 (COVID-19) ของประชาชนไทย

description: การศึกษาเรื่อง ปัจจัยที่มีผลต่อความตั้งใจรับวัคซีนโควิด 19 (COVID-19) ของประชาชนไทย มีวัตถุประสงค์เพื่อศึกษาปัจจัยที่มีผลต่อการยอมรับและตั้งใจรับวัคซีนโควิด 19 โดยสามารถนำผลการวิจัยไปใช้เป็นแนวทางในการวางแผนและนโยบายในการระดมฉีดวัคซีนโควิด 19 ให้กับประชาชนไทยของรัฐบาล และส่งเสริมความตั้งใจในการรับวัคซีนโควิด 19 ของประชาชนไทย กรอบการวิจัยในการศึกษานี้ประยุกต์จากทฤษฎีแบบแผนความเชื่อด้านสุขภาพ (Health Belief Model) กลุ่มตัวอย่างที่ใช้ในการศึกษาคือประชาชนไทย ที่อาศัยอยู่ในประเทศไทยมีอายุตั้งแต่ 18 ปีขึ้นไป จำนวน 372 คน โดยการรวบรวมข้อมูลจากแบบสอบถามและนำไปวิเคราะห์ทางสถิติโดยใช้โปรแกรม Statistical Package for the Social Sciences (SPSS) เพื่อหาค่าร้อยละ ค่าเฉลี่ย ค่าเบี่ยงเบนมาตรฐาน จัดกลุ่มความสัมพันธ์ของตัวแปร และการวิเคราะห์การถดถอยพหุคูณ จากผลการสำรวจกลุ่มตัวอย่าง 372 คนและวิเคราะห์ข้อมูลสามารถสรุปผลการวิจัยได้ว่า ปัจจัยที่มีผลต่อความตั้งใจรับวัคซีนโควิด 19 ของประชาชนไทย มีทั้งสิ้น 2 ปัจจัย คือ การรับรู้ประโยชน์จากการรับวัคซีนโควิด 19 และการรับรู้ความกังวลเกี่ยวกับผลข้างเคียงจากการรับวัคซีนโควิด 19
DOI: 10.14457/cu.the.1997.408
title: Effect of diblock copolymer as a compatibilizer for immiscible blends
DOI: 10.48370/ofd/glcjoc/llbp8v
title: HMW_Veronica_triphyllos_L._H_0130.jpg

description: :unav
DOI: 10.48370/ofd/glcjoc
title: Przetacznik trójlistkowy (Veronica triphyllos L.), 130

description: Herbarium
DOI: 10.48370/ofd/3cai5y/2n9fbs
title: HMW_Veronica_triphyllos_L._H_1144.jpg

description: :unav
DOI: 10.48370/ofd/3cai5y
title: Przetacznik trójlistkowy (Veronica triphyllos L.), 1144

description: Herbarium
DOI: 10.48370/ofd/uuj6o2/c1jtlj
title: HMW_Veronica_triphyllos_L._H_4854.jpg

description: :unav
DOI: 10.48370/ofd/uuj6o2
title: Przetacznik trójlistkowy (Veronica triphyllos L.), 4854

description: Herbarium
DOI: 10.48370/ofd/exixyl/lxdhtd
title: HMW_Veronica_triphyllos_L._H_7012.jpg

description: :unav
DOI: 10.48370/ofd/exixyl
title: Przetacznik trójlistkowy (Veronica triphyllos L.), 7012

description: Herbarium
DOI: 10.5281/zenodo.5497447
title: PRASTOF - Results

description: The PRASTOF (PRospective Aluminium STOck and Flows) open-source Python software aims to generate scenarios for future stocks and flows of aluminium alloys and alloying elements in line with the Shared socioeconomic pathways (SSP) framework in order to understanding the stock dynamics of this resource and enhance a better management of it towards a more sustainable and circular economy. A bottom-up approach that considers each final use sector individually was chosen to better depict the details regarding sectoral material demand, lifetimes, and alloys composition. This data set regroup all results of PRASTOF. Data and code used to calculate the scenarios are available here: https://github.com/jpedneault/PRASTOF
DOI: 10.48370/ofd/k93tgu/llobn5
title: HMW_Veronica_triphyllos_L._H_7177.jpg

description: :unav
DOI: 10.48370/ofd/k93tgu
title: Przetacznik trójlistkowy (Veronica triphyllos L.), 7177

description: Herbarium
DOI: 10.48370/ofd/faepla/uenm4n
title: HMW_Veronica_triphyllos_L._H_7593.jpg

description: :unav
DOI: 10.48370/ofd/faepla
title: Przetacznik trójlistkowy (Veronica triphyllos L.), 7593

description: Herbarium
DOI: 10.48370/ofd/mph7bm/gfmmoy
title: HMW_Veronica_urticifolia_Jacq._H_05177.jpg

description: :unav
DOI: 10.48370/ofd/mph7bm
title: Przetacznik pokrzywolistny (Veronica urticifolia Jacq.), 5177

description: Herbarium
DOI: 10.5281/zenodo.5186356
title: Gas-Induced Drying of Nanopores

description: Research data associated with the publication: <em>J. Phys. Chem. Lett.</em> 2020, 11, 21, 9171–9177 https://doi.org/10.1021/acs.jpclett.0c02600 Description of the data format can be found inside the folders.
DOI: 10.5281/zenodo.5186355
title: Gas-Induced Drying of Nanopores

description: Research data associated with the publication: <em>J. Phys. Chem. Lett.</em> 2020, 11, 21, 9171–9177 https://doi.org/10.1021/acs.jpclett.0c02600 Description of the data format can be found inside the folders.
DOI: 10.6084/m9.figshare.16601168
title: Supplementary Material for: Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer’s Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial

description: <b><i>Background:</i></b> Donepezil 23 mg is considered for Alzheimer’s disease (AD) to optimize cognitive benefits; however, increased adverse events (AEs) can negatively influence drug adherence. We investigated whether body weight (BW) differs based on the presence of AEs, and which baseline factors were relevant to the safety of high-dose donepezil. <b><i>Methods:</i></b> This study was a post hoc analysis of a multicenter randomized trial between 2014 and 2016. We included patients with moderate to severe AD treated with 10 mg/day of donepezil, and the daily dose was escalated to 23 mg with/without dose titration. Dose titration indicates 15 mg/day of donepezil before escalation or 10 mg and 23 mg/day on alternate days before escalation during the first 4 weeks. The patients were divided into 2 groups based on occurrence of AEs of special interest (AESIs) to compare baseline characteristics. We also assessed relationships between BW and AESIs. <b><i>Results:</i></b> Among the 160 participants in the safety population, the baseline BWs differed between the AESI (+) (<i>n</i> = 67) and AESI (−) (<i>n</i> = 93) groups. Baseline BW was inversely correlated with the occurrence of AESIs (<i>p</i> = 0.020), and this relationship was prominent in the no-dose titration group (<i>p</i> = 0.009) but absent in the dose-titration groups (<i>p</i> &gt; 0.05). <b><i>Conclusions:</i></b> BW is the most important factor that correlated with cholinergic AEs. Hence, stepwise dose titration should be considered, particularly in patients with low BW, to minimize the inverse relationship between BW and the occurrence of AEs (“Clinicaltrials.gov” No. NCT02550665 registered on September 15, 2015).
DOI: 10.6084/m9.figshare.16601168.v1
title: Supplementary Material for: Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer’s Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial

description: <b><i>Background:</i></b> Donepezil 23 mg is considered for Alzheimer’s disease (AD) to optimize cognitive benefits; however, increased adverse events (AEs) can negatively influence drug adherence. We investigated whether body weight (BW) differs based on the presence of AEs, and which baseline factors were relevant to the safety of high-dose donepezil. <b><i>Methods:</i></b> This study was a post hoc analysis of a multicenter randomized trial between 2014 and 2016. We included patients with moderate to severe AD treated with 10 mg/day of donepezil, and the daily dose was escalated to 23 mg with/without dose titration. Dose titration indicates 15 mg/day of donepezil before escalation or 10 mg and 23 mg/day on alternate days before escalation during the first 4 weeks. The patients were divided into 2 groups based on occurrence of AEs of special interest (AESIs) to compare baseline characteristics. We also assessed relationships between BW and AESIs. <b><i>Results:</i></b> Among the 160 participants in the safety population, the baseline BWs differed between the AESI (+) (<i>n</i> = 67) and AESI (−) (<i>n</i> = 93) groups. Baseline BW was inversely correlated with the occurrence of AESIs (<i>p</i> = 0.020), and this relationship was prominent in the no-dose titration group (<i>p</i> = 0.009) but absent in the dose-titration groups (<i>p</i> &gt; 0.05). <b><i>Conclusions:</i></b> BW is the most important factor that correlated with cholinergic AEs. Hence, stepwise dose titration should be considered, particularly in patients with low BW, to minimize the inverse relationship between BW and the occurrence of AEs (“Clinicaltrials.gov” No. NCT02550665 registered on September 15, 2015).
DOI: 10.6084/m9.figshare.16601246
title: Supplementary Material for: C-X-C Motif Chemokine Ligand 16 Is a Potent Predictor of Outcomes in Dialysis Patients

description: <b><i>Introduction:</i></b> C-X-C motif chemokine ligand 16 (CXCL16) is an inflammatory marker that has been found to be predictive of outcomes in patients with cardiovascular disease. Our previous work has also demonstrated its relation to cardiac injury in dialysis patients. However, it is yet unclear whether there is an association between CXCL16 and adverse outcomes in dialysis patients. We aimed to evaluate its prognostic value along with several traditional inflammatory markers in the current study. <b><i>Methods:</i></b> This is a multicenter longitudinal study of prevalent dialysis patients. Circulating inflammatory markers including CXCL16, C-reactive protein (CRP), tumor necrosis factor-α, and interleukin-6 (IL-6) were measured using a multiplex assay. The primary outcomes were all-cause mortality and a composite of major adverse cardiovascular events (MACEs). The associations between biomarkers and outcomes were analyzed using Cox proportional hazards regression models. <b><i>Results:</i></b> Of the 366 participants with available plasma samples, the average age was 52.5 (±12.1) years, and there were 160 (43.7%) female participants. For all-cause mortality, logarithmically transformed CXCL16, IL-6, and CRP were independent predictors after adjustment for covariates. When the 3 markers were included in the same model, CXCL16 was the only one remaining its significance. For MACEs, logarithmically transformed CXCL16 and IL-6 were significant predictors when analyzed separately and CXCL16 was an independent predictor even after adjustment for IL-6. When the biomarkers were analyzed as categorical variables, only CXCL16 was associated with both outcomes. Adding CXCL16 to established risk factors improved risk prediction as revealed by Net Reclassification Index (NRI). <b><i>Conclusion:</i></b> Using a multimarker approach, we determined that CXCL16 is a potent predictor of all-cause mortality and cardiovascular events in dialysis patients. Our data suggest CXCL16 may improve risk stratification and could be a potential interventional target.
DOI: 10.6084/m9.figshare.16601174
title: Supplementary Material for: Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients

description: <b><i>Introduction:</i></b> Dialysis patients are often prescribed a large number of medications to improve metabolic control and manage coexisting comorbidities. However, some studies suggest that a large number of medications could also detrimentally affect patients’ health-related quality of life (HRQoL). Therefore, this study aims to provide insight in the association between the number of types of medications and HRQoL in dialysis patients. <b><i>Methods:</i></b> A multicentre cohort study was conducted among dialysis patients from Dutch dialysis centres 3 months after initiation of dialysis as part of the ongoing prospective DOMESTICO study. The number of types of medications, defined as the number of concomitantly prescribed types of drugs, was obtained from electronic patient records. Primary outcome was HRQoL measured with the Physical Component Summary (PCS) score and Mental Component Summary (MCS) score (range 0–100) of the Short Form 12. Secondary outcomes were number of symptoms (range 0–30) measured with the Dialysis Symptoms Index and self-rated health (range 0–100) measured with the EuroQol-5D-5L. Data were analysed using linear regression and adjusted for possible confounders, including comorbidity. Analyses for MCS and number of symptoms were performed after categorizing patients in tertiles according to their number of medications because assumptions of linearity were violated for these outcomes. <b><i>Results:</i></b> A total of 162 patients were included. Mean age of patients was 58 ± 17 years, 35% were female, and 80% underwent haemodialysis. The mean number of medications was 12.2 ± 4.5. Mean PCS and MCS were 36.6 ± 10.2 and 46.8 ± 10.0, respectively. The mean number of symptoms was 12.3 ± 6.9 and the mean self-rated health 60.1 ± 20.6. In adjusted analyses, PCS was 0.6 point lower for each additional medication (95% confidence interval [95% CI]: −0.9 to –0.2; <i>p</i> = 0.002). MCS was 4.9 point lower (95% CI: −8.8 to –1.0; <i>p</i> = 0.01) and 1.0 point lower (95% CI: −5.1–3.1; <i>p</i> = 0.63) for the highest and middle tertiles of medications, respectively, than for the lowest tertile. Patients in the highest tertile of medications reported 4.1 more symptoms than in the lowest tertile (95% CI: 1.5–6.6; <i>p</i> = 0.002), but no significant difference in the number of symptoms was observed between the middle and lowest tertiles. Self-rated health was 1.5 point lower for each medication (95% CI: −2.2 to –0.7; <i>p</i> &lt; 0.001). <b><i>Discussion/Conclusion:</i></b> After adjustment for comorbidity and other confounders, a higher number of medications were associated with a lower PCS, MCS, and self-rated health in dialysis patients and with more symptoms.